Search results
Bristol Myers' (BMY) Opdivo SC Meets Kidney Cancer Study Goals
Zacks via Yahoo Finance· 7 months agoBristol Myers' (BMY) subcutaneous formulation of Opdivo, developed using Halozyme's Enhanze...
Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney...
Benzinga via Yahoo Finance· 4 months agoBristol Myers Squibb & Co (NYSE:BMY) announced that Opdivo (nivolumab) plus Yervoy (ipilimumab)...
Bristol Myers' (BMY) Opdivo Combos Get FDA Nod for ESCC
Zacks via Yahoo Finance· 2 years agoBristol Myers (BMY) secures an FDA approval for two Opdivo-based regimens as the first-line...
Exelixis (EXEL) Cabometyx Combo Study Meets Primary Goal
Zacks via Yahoo Finance· 2 years agoExelixis'(EXEL) late-stage study evaluating the combination of Cabometyx and Opdivo and Yervoy...
Bristol Myers drug combo fails to meet main goal in kidney cancer trial
Reuters via Yahoo News· 2 years agoYervoy and top selling cancer drug Opdivo - is already approved in the United States as a first line...
Bristol Myers (BMY) Announces Upbeat Data From NSCLC Study
Zacks via Yahoo Finance· 11 months agoBristol Myers (BMY) reports encouraging four-year clinical efficacy results from its lung cancer...
Bristol Myers (BMY) Phase III CheckMate -901 Study Disappoints
Zacks via Yahoo Finance· 2 years agoBristol Myers (BMY) phase III CheckMate -901 study fails to meet the primary endpoint of overall...
Iovance (IOVA) to Buy Clinigen's Cancer Drug, Stock Up 11.6%
Zacks via Yahoo Finance· 1 year agoIovance (IOVA) to acquire worldwide rights to an IL-2 product already approved by FDA for two cancer...
Why Is Exelixis (EXEL) Down 8.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Exelixis (EXEL). Shares have lost about 8.8%...
Bristol Myers (BMY) to Buy Cancer Drug-Maker RayzeBio for $4.1B
Zacks via Yahoo Finance· 4 months agoBristol Myers (BMY) is set to acquire RayzeBio for $4.1 billion to strengthen and diversify its...